Literature DB >> 18307051

Effect of dehydroepiandrosterone (DHEA) on monoamine oxidase activity, lipid peroxidation and lipofuscin accumulation in aging rat brain regions.

Pardeep Kumar1, Asia Taha, Deepak Sharma, R K Kale, Najma Z Baquer.   

Abstract

Dehydroepiandrosterone (DHEA), one of the major steroid hormones, and its ester have recently received attention with regard to aging and age-related diseases like Alzheimer and others. DHEA is synthesized de novo in the brain and its substantial fall with age has been shown to be associated with neuronal vulnerability to neurotoxicity processes. Thus, DHEA is considered to be a neuroactive pharmacological substance with potential antiaging properties. A prominent feature that accompanies aging is an increase in monoamine oxidase (MAO). Increased MAO activity with correlated increase in lipid peroxidation in the aging rat brain supports the hypothesis that catecholamine oxidation is an important source of oxidative stress. The progressive accumulation of lipofuscin in neuronal cells is one of the most characteristic age related changes, an increase in body weight was also observed at 24 months. The objective of this study was to observe the changes in monoamine oxidase activity, lipid peroxidation levels and lipofuscin accumulation occurring in aging rat brain regions, and to see whether these changes are restored to normal levels after exogenous administration of DHEA (30 mg/kg/day for 1 month). The results obtained in the present work revealed that normal aging was associated with significant increases in the activity of monoamine oxidase, lipid peroxidation levels and lipofuscin accumulation in brain regions of 4, 14 and 24 months age group male rats. The present study showed that DHEA treatment significantly decreased monoamine oxidase activity, lipid peroxidation and lipofuscin accumulation in brain regions of aging rats, the increased body weight at 24 months also decreased more than the age matched controls. It can therefore be suggested that DHEA's beneficial effects seemed to arise from its antioxidant, antiobesity, antilipofuscin, antilipidperoxidative and thereby anti-aging actions. The results of this study will be useful for pharmacological modification of the aging process and development of new drugs for age related disorders.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18307051     DOI: 10.1007/s10522-008-9133-y

Source DB:  PubMed          Journal:  Biogerontology        ISSN: 1389-5729            Impact factor:   4.277


  4 in total

Review 1.  Dehydroepiandrosterone and age-related cognitive decline.

Authors:  Krystina G Sorwell; Henryk F Urbanski
Journal:  Age (Dordr)       Date:  2009-08-27

2.  Estradiol modulates membrane-linked ATPases, antioxidant enzymes, membrane fluidity, lipid peroxidation, and lipofuscin in aged rat liver.

Authors:  Pardeep Kumar; R K Kale; Najma Zaheer Baquer
Journal:  J Aging Res       Date:  2011-10-09

Review 3.  Central intracrine DHEA synthesis in ageing-related neuroinflammation and neurodegeneration: therapeutic potential?

Authors:  Y S L Powrie; C Smith
Journal:  J Neuroinflammation       Date:  2018-10-16       Impact factor: 8.322

4.  In vitro and in vivo tenocyte-protective effectiveness of dehydroepiandrosterone against high glucose-induced oxidative stress.

Authors:  Shintaro Mukohara; Yutaka Mifune; Atsuyuki Inui; Hanako Nishimoto; Takashi Kurosawa; Kohei Yamaura; Tomoya Yoshikawa; Ryosuke Kuroda
Journal:  BMC Musculoskelet Disord       Date:  2021-06-05       Impact factor: 2.362

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.